Literature DB >> 16944043

The QT interval and psychotropic medications in children: recommendations for clinicians.

Paul McNally1, Fiona McNicholas, Paul Oslizlok.   

Abstract

The use of psychotropic medications in children has increased significantly in the last few years. There have been several case reports of sudden death in children taking specific psychotropic medications. Fears that these deaths might have been caused by ventricular arrhythmias have been enhanced by reports of electrocardiographic abnormalities, including prolongation of the QTc interval, in patients taking these medications. Several factors including genetic susceptibility, pre-existing cardiac disease, abnormalities of drug clearance and concomitant use of other medications known to affect the QTc interval can increase the susceptibility of the heart to conduction abnormalities. This article discusses the potential of particular psychotropic drugs to prolong the QTc interval in children, and examines other factors that may contribute to conduction abnormalities. We aim to provide clear clinical recommendations for the prescription of these drugs and the monitoring of children taking them.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944043     DOI: 10.1007/s00787-006-0573-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  136 in total

1.  Prolonged QT interval after trazodone overdose.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

2.  Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome.

Authors:  Kuan-Pin Su; Hsien-Yuan Lane; Chiao-Lin Chuang; Kun-Po Chen; Winston W Shen
Journal:  Schizophr Res       Date:  2004-02-01       Impact factor: 4.939

3.  ADHD drugs and cardiovascular risk.

Authors:  Steven E Nissen
Journal:  N Engl J Med       Date:  2006-03-20       Impact factor: 91.245

Review 4.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.

Authors:  T E Wilens; J Biederman; R J Baldessarini; B Geller; D Schleifer; T J Spencer; B Birmaher; A Goldblatt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-11       Impact factor: 8.829

5.  Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.

Authors:  L P Perrault; A Y Denault; M Carrier; R Cartier; S Bélisle
Journal:  Can J Anaesth       Date:  2000-03       Impact factor: 5.063

6.  Citalopram-induced bradycardia and presyncope.

Authors:  G K Isbister; F H Prior; A Foy
Journal:  Ann Pharmacother       Date:  2001-12       Impact factor: 3.154

7.  Sudden death of a child treated with imipramine. Case study.

Authors:  C K Varley
Journal:  J Child Adolesc Psychopharmacol       Date:  2000       Impact factor: 2.576

Review 8.  Fatalities associated with therapeutic use and overdose of atypical antipsychotics.

Authors:  Adam Trenton; Glenn Currier; Frank Zwemer
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Authors:  Peter M Haddad; Ian M Anderson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium.

Authors:  Pascale Gluais; Michèle Bastide; Daniel Grandmougin; Georges Fayad; Monique Adamantidis
Journal:  Eur J Pharmacol       Date:  2004-08-23       Impact factor: 4.432

View more
  5 in total

1.  Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment.

Authors:  Eitan Nahshoni; Pavel Golubchik; Jonathan Glazer; Jonathan Sever; Boris Strasberg; Shula Imbar; Gal Shoval; Abraham Weizman; Gil Zalsman
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-12-11       Impact factor: 4.785

2.  No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.

Authors:  Lan Chi Vo; Christopher Snyder; Courtney McCracken; Christopher J McDougle; James T McCracken; Michael G Aman; Elaine Tierney; L Eugene Arnold; Daniel Levi; Michael Kelleman; Deirdre Carroll; John Morrissey; Benedetto Vitiello; Lawrence Scahill
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-10-11       Impact factor: 2.576

3.  Management of Psychiatric Disorders in Patients with Cardiovascular Diseases.

Authors:  Prasad Rao Gundugurti; Ranjan Bhattacharyya; Amulya Koneru
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

4.  The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Authors:  Jason G Ho; Randall L Caldwell; Christopher J McDougle; Danielle K Orsagh-Yentis; Craig A Erickson; David J Posey; Kimberly A Stigler
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-07-31       Impact factor: 2.576

5.  Psychiatric disorder and incessant tachyarrhythmia in a child.

Authors:  Peter Chau; Jeremy Moore
Journal:  Case Rep Pediatr       Date:  2013-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.